Breaking News Instant updates and real-time market news.

TSN

Tyson Foods

$80.75

1.16 (1.46%)

, KO

Coca-Cola

$49.00

0.93 (1.93%)

10:06
05/14/19
05/14
10:06
05/14/19
10:06

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tyson Foods (TSN) upgraded to Outperform from Neutral at Credit Suisse and to Buy from Hold at Argus. 2. Coca-Cola (KO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying the company's growth outlook is "clearly superior" relative to the packaged goods space, but this is not reflected in the current share price. 3. Capital One (COF) upgraded to Buy from Hold at Jefferies with analyst John Hecht saying he expects the stock to benefit from "bigger payouts and improving efficiencies." 4. Deckers Brands (DECK) upgraded to Positive from Neutral at Susquehanna. 5. Agco (AGCO) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying given Agco's limited exposure to the U.S. row crop sector, the recent sell-off in the shares is overdone. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TSN

Tyson Foods

$80.75

1.16 (1.46%)

KO

Coca-Cola

$49.00

0.93 (1.93%)

COF

Capital One

$88.32

0.77 (0.88%)

DECK

Deckers Brands

$142.17

3.98 (2.88%)

AGCO

Agco

$70.77

0.23 (0.33%)

  • 16

    May

  • 23

    May

  • 05

    Jun

  • 11

    Jun

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

TSN Tyson Foods
$80.75

1.16 (1.46%)

05/14/19
FBCO
05/14/19
UPGRADE
FBCO
Outperform
Tyson Foods upgraded to Outperform from Neutral at Credit Suisse
05/14/19
05/14/19
UPGRADE
Target $96

Outperform
Tyson Foods upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Robert Moskow upgraded Tyson Foods to Outperform from Neutral and raised his price target on the shares to $96 from $74. The analyst notes that consensus estimates already factor in stronger Chicken margins based on a rebound in the U.S. supply-demand cycle domestically. However, he does not think they fully account for the upside to chicken, beef, and pork prices from the outbreak of African Swine Fever.
05/14/19
ARGS
05/14/19
UPGRADE
ARGS
Buy
Tyson Foods upgraded to Buy from Hold at Argus
Argus analyst John Staszak upgraded Tyson Foods to Buy with a price target of $92, also raising his FY19 EPS view by 10c to $6.20 and his FY20 target by 25c to $6.75. The analyst contends that the "growing demand for proteins" is positive for the company and other meat processors, with Tyson's beef division seeing an "especially strong demand". Staszak further cites the company's efforts to increase sales of prepared foods to meet the "steady demand and strong margins" while noting the 12.8-times forward earnings multiple on Tyson Foods stock, which is below the average large-cap food processor multiple of 18.4-times and in the lower half of its historical 9- to 19-times range.
05/14/19
ARGS
05/14/19
UPGRADE
ARGS
Buy
Tyson Foods upgraded to Buy from Hold at Argus
KO Coca-Cola
$49.00

0.93 (1.93%)

05/14/19
MSCO
05/14/19
UPGRADE
Target $55
MSCO
Overweight
Coca-Cola upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian upgraded Coca-Cola to Overweight from Equal Weight and raised his price target for the shares to $55 from $52. The company's growth outlook is "clearly superior" relative to the packaged goods space, but this is not reflected in the current share price, Mohsenian tells investors in a research note. Coca-Cola's valuation discount is "unfair" as it offers structurally higher sales growth compared to peers, adds the analyst. Mohsenian attributes the company's below-consensus 2019 guidance to currency and feels it should have a minimal impact on Coca-Cola's valuation.
05/14/19
ARGS
05/14/19
NO CHANGE
ARGS
Hold
Argus looking for 'favorable entry point' in Coca-Cola
Argus analyst Chris Graja kept his Hold rating on Coca-Cola, but says that he is looking for a "favorable entry point" on the stock and would "strongly consider" an upgrade to his rating at a price of $40-$42 per share. The analyst sees the company as "reasonably valued" based on his projected 8% earnings growth rate as well as his view of Coca-Cola's financial strength and ability to deploy cash.
03/29/19
WELS
03/29/19
NO CHANGE
WELS
Coca-Cola energy drink launch in Europe negative for Monster, says Wells Fargo
Coca-Cola (KO) yesterday announced plans to launch its first ever energy drink in Europe, Wells Fargo analyst Bonnie Herzog tells investors in a research note titled "KO Unleashes Its Own 'Monster' with Coke Energy in Europe." Importantly, the announcement came despite the fact that Coca-Cola's ongoing arbitration with Monster Beverage (MNST) has not concluded, says the analyst. She believes this "clearly signals" that Coca-Cola is increasingly confident that it will prevail in the arbitration process. Herzog views the development as a negative for Monster "given that a Coca-Cola-branded energy drink represents yet another source of competition." She thinks the risks are increasing for Market Perform-rated Monster "from multiple vantage points" and maintains his cautious view on the stock.
04/11/19
MSCO
04/11/19
DOWNGRADE
Target $24
MSCO
Underweight
Morgan Stanley downgrades Keurig Dr Pepper to Underweight on coffee risk
As previously reported, Morgan Stanley analyst Dara Mohsenian downgraded Keurig Dr Pepper to Underweight from Equal Weight as he sees a negative risk-reward despite a "well telegraphed" Q1 earnings beat on strong pricing at heritage Dr. Pepper Snapple. Based on the firm's recent AlphaWise survey, the analyst sees risk to coffee growth, noting that his forecast of around 1.5% is below the market-implied 4% long-term coffee topline growth, which is a key driver of his EPS forecast by 2021 being 5% below consensus. Additionally, Keurig Dr Pepper shares trade at a premium to the average of beverage peers Coca-Cola (KO) and PepsiCo (PEP) despite lower expected long-term topline growth, Mohsenian noted. He cut his price target on Keurig Dr Pepper shares to $24 from $27.
COF Capital One
$88.32

0.77 (0.88%)

05/14/19
JEFF
05/14/19
UPGRADE
Target $115
JEFF
Buy
Capital One upgraded to Buy from Hold at Jefferies
Jefferies analyst John Hecht upgraded Capital One Financial to Buy from Hold and raised his price target for the shares to $115 from $95.
02/26/19
02/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Exact Sciences (EXAS) upgraded to Buy from Neutral at Goldman Sachs by analyst Patrick Donnelly, who said the current momentum of the Cologuard commercial ramp provides "strong basis" for the company's premium valuation while the combination of positive Cologuard catalysts and new product roll-outs provide upside to current levels, even after the stock's 75% rally since the beginning of 2018. Exact Sciences is a "must-own growth stock" given the "clean runway forward that is largely in its control with potential for discovery value in the pipeline outside of Cologuard," the analyst said. 2. Siemens (SIEGY) upgraded to Overweight from Neutral at JPMorgan by analyst Andreas Willi, who sees a relative valuation opportunity after the stock's 27% underperformance over the past two years. He believes investor sentiment can improve "after a period where the story has drifted." 3. Kadmon (KDMN) upgraded to Buy from Neutral at Citi by analyst Robyn Karnauskas, who assigned a 50% probability to KD-025 in chronic graft versus host disease with an unadjusted ~$900M market opportunity. However, upside to the stock will depend on quality of the data likely, Karnauskas said. 4. EverQuote (EVER) upgraded to Buy following Q4 beat at BofA/Merrill by analyst Mat Schindler, who said user growth has re-accelerated, supporting evidence of a turnaround, and thinks estimates are conservative and views the risk/reward as attractive. 5. Ally Financial (ALLY) upgraded to Buy from Hold at Sandler O'Neill by analyst Christopher Donat, who said he believes Ally's near-prime auto finance book is "meaningfully less risky" than Santander Consumer's (SC) book or the unsecured credit cards of Discover (DFS) and Capital One (COF), yet all four stocks trade at similar multiples. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/19
RBCM
05/03/19
INITIATION
Target $98
RBCM
Sector Perform
Capital One assumed with a Sector Perform at RBC Capital
RBC Capital analyst Jon Arfstrom assumed coverage of Capital One with a Sector Perform rating and a price target of $98, saying the company's "commitment to technology" is impressive as it makes the appropriate investment decision to build a durable franchise. The analyst adds however that based on his expectations of healthy credit trends, he prefers stocks that offer exposure to "faster growing consumer receivables businesses."
05/14/19
JEFF
05/14/19
UPGRADE
Target $115
JEFF
Buy
Jefferies upgrades Capital One to Buy from Hold with $115 price target
Jefferies analyst John Hecht upgraded Capital One Financial to Buy from Hold and raised his price target for the shares to $115 from $95. The analyst expects the stock to benefit from "bigger payouts and improving efficiencies." Capital One's digital bank is "meaningfully" ahead of peers, which should accrue "meaningfully" to shareholders within three-to-five years, Hecht tells investors in a research note. The company's digital bank initiative will enable operating efficiencies that should provide a platform for earnings growth, adds the analyst. Further, he sees Capital One improving its payout ratio, providing more return to shareholders, as well as an attractive valuation at current share levels.
DECK Deckers Brands
$142.17

3.98 (2.88%)

02/27/19
SUSQ
02/27/19
DOWNGRADE
SUSQ
Neutral
Deckers Brands downgraded to Neutral from Positive at Susquehanna
05/14/19
SUSQ
05/14/19
UPGRADE
SUSQ
Positive
Deckers Brands upgraded to Positive from Neutral at Susquehanna
01/31/19
TLSY
01/31/19
DOWNGRADE
Target $37
TLSY
Market Perform
Telsey Advisory downgrades Steven Madden to Market Perform with $37 target
Telsey Advisory analyst Dana Telsey downgraded Steven Madden (SHOO) to Market Perform from Outperform and lowered her price target for the shares to $37 from $40. The analyst this morning also upgraded Ralph Lauren (RL) to Outperform from Market Perform. While Steven Madden has a lot to like, external factors, such as tariffs and a wholesale channel that has a "more muted tone" entering 2019 as compared to 2018, may weigh on the stock price, Telsey tells investors in a research note. The analyst's top pick in footwear remains Deckers Brands (DECK).
02/01/19
ADAM
02/01/19
NO CHANGE
Target $164
ADAM
Buy
Deckers Brands price target raised to $164 from $143 at Canaccord
Canaccord analyst Camilo Lyon raised his price target on Deckers Brands to $164 from $143 following Q3 results that he called "very strong." The analyst said it was a high quality beat and he cited favorable weather and its new allocation and segmentation strategy for driving the majority of outperformance. Lyon reiterated his Buy rating on Deckers Brands shares.
AGCO Agco
$70.77

0.23 (0.33%)

05/14/19
JPMS
05/14/19
UPGRADE
Target $77
JPMS
Overweight
Agco upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Ann Duignan upgraded Agco (AGCO) to Overweight from Neutral and raised her price target for the shares to $77 from $66. The analyst coupled the upgrade with a downgrade of Deere (DE) to Underweight from Neutral. Given Agco's limited exposure to the U.S. row crop sector, the recent sell-off in the shares is overdone, Duignan tells investors in a research note. She sees a good entry point at current share levels.
05/14/19
JPMS
05/14/19
DOWNGRADE
Target $132
JPMS
Underweight
Deere downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Ann Duignan downgraded Deere (DE) to Underweight from Neutral and lowered her price target for the shares to $132 from $154. The analyst coupled the downgrade with an upgrade of Agco (AGCO) to Overweight from Neutral. The analyst sees "rapidly deteriorating" fundamentals in U.S. agriculture. Beyond tariffs, Chinese import demand for soybeans is likely to decline significantly as it deals with a ~30% reduction in its hog herd following the outbreak of African swine fever, Duignan tells investors in a research note. Further, Brazil and Argentina combined have produced close to record soybean and corn crops this season, while U.S. dollar strength remains a headwind for U.S. competitiveness on the global market, adds the analyst. She sees a "perfect storm" for U.S. farmers and believes the fundamentals for Deere are now skewed to the downside.
05/07/19
RBCM
05/07/19
NO CHANGE
Target $86
RBCM
Outperform
Agco price target raised to $86 from $76 at RBC Capital
RBC Capital analyst Seth Weber raised his price target on Agco to $86 and kept his Outperform rating after the company's Q1 earnings beat last week as well as his meetings with its management. The analyst sees the stock among his "top ideas", saying its pure-play farm equipment status positions it well for a rebound in industry demand that is expected to materialize in 2020. Weber also anticipates market share gains and margin driving initiatives from Agco, raising his FY19 and FY20 EPS view by 25c and 15c to $4.95 and $5.75 respectively.
04/25/19
OTRG
04/25/19
DOWNGRADE
OTRG
Mixed
OTR Global lowers view on farm equipment manufacturers to Mixed from Positive
OTR Global lowered its view on farm equipment manufacturers, which includes Agco (AGCO), CNH Industrial (CNHI) and Deere (DE), to Mixed from Positive in January, noting that global farm equipment sales for 2019 are now expected to be up 1%-5% year-over-year, versus expectations of up 2%-5% in January.

TODAY'S FREE FLY STORIES

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$9.12

-0.09 (-0.98%)

16:14
05/24/19
05/24
16:14
05/24/19
16:14
Syndicate
Breaking Syndicate news story on Translate Bio »

Translate Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.